These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36456532)

  • 21. MIDGET:Detecting differential gene expression on microarray data.
    Angelescu R; Dobrescu R
    Comput Methods Programs Biomed; 2021 Nov; 211():106418. PubMed ID: 34555591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benchmarking Molecular Feature Attribution Methods with Activity Cliffs.
    Jiménez-Luna J; Skalic M; Weskamp N
    J Chem Inf Model; 2022 Jan; 62(2):274-283. PubMed ID: 35019265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analogues.
    Furtmann N; Hu Y; Bajorath J
    J Med Chem; 2015 Jan; 58(1):252-64. PubMed ID: 25054653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of single- and multi-target activity cliffs formed by currently available bioactive compounds.
    Wassermann AM; Dimova D; Bajorath J
    Chem Biol Drug Des; 2011 Aug; 78(2):224-8. PubMed ID: 21624090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical landscape analysis with the OpenTox framework.
    Jeliazkova N; Jeliazkov V
    Curr Top Med Chem; 2012; 12(18):1987-2001. PubMed ID: 23110534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs.
    Yin Y; Hu H; Yang J; Ye C; Goh WWB; Kong AW; Wu J
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38889277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing the activity cliff concept.
    Hu Y; Stumpfe D; Bajorath J
    F1000Res; 2013; 2():199. PubMed ID: 24555097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity cliffs and activity cliff generators based on chemotype-related activity landscapes.
    Pérez-Villanueva J; Méndez-Lucio O; Soria-Arteche O; Medina-Franco JL
    Mol Divers; 2015 Nov; 19(4):1021-35. PubMed ID: 26150300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity cliffs in PubChem confirmatory bioassays taking inactive compounds into account.
    Hu Y; Maggiora GM; Bajorath J
    J Comput Aided Mol Des; 2013 Feb; 27(2):115-24. PubMed ID: 23296990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing multitarget activity landscapes using protein-ligand interaction fingerprints: interaction cliffs.
    Méndez-Lucio O; Kooistra AJ; de Graaf C; Bender A; Medina-Franco JL
    J Chem Inf Model; 2015 Feb; 55(2):251-62. PubMed ID: 25615841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-scale prediction of activity cliffs using machine and deep learning methods of increasing complexity.
    Tamura S; Miyao T; Bajorath J
    J Cheminform; 2023 Jan; 15(1):4. PubMed ID: 36611204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Activity Cliffs from a Chemoinformatics Perspective.
    Bajorath J
    Mol Inform; 2014 Jun; 33(6-7):438-42. PubMed ID: 27485979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of occurrence and potency range distribution of activity cliffs in bioactive compounds.
    Stumpfe D; Bajorath J
    J Chem Inf Model; 2012 Sep; 52(9):2348-53. PubMed ID: 22866827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decision-theoretic approach to the evaluation of machine learning algorithms in computational drug discovery.
    Watson OP; Cortes-Ciriano I; Taylor AR; Watson JA
    Bioinformatics; 2019 Nov; 35(22):4656-4663. PubMed ID: 31070704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validating the validation: reanalyzing a large-scale comparison of deep learning and machine learning models for bioactivity prediction.
    Robinson MC; Glen RC; Lee AA
    J Comput Aided Mol Des; 2020 Jul; 34(7):717-730. PubMed ID: 31960253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From activity cliffs to target-specific scoring models and pharmacophore hypotheses.
    Seebeck B; Wagener M; Rarey M
    ChemMedChem; 2011 Sep; 6(9):1630-9, 1533. PubMed ID: 21751401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of target cliffs as a concept to identify and describe complex molecular selectivity patterns.
    Hu Y; Bajorath J
    J Chem Inf Model; 2013 Mar; 53(3):545-52. PubMed ID: 23379346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in Activity Cliff Research.
    Dimova D; Bajorath J
    Mol Inform; 2016 May; 35(5):181-91. PubMed ID: 27492084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR.
    Winkler DA; Le TC
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27783464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.